BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 36354709)

  • 21. Clinical Outcomes of Patients With Recurrent Lung Cancer Reirradiated With Proton Therapy on the Proton Collaborative Group and University of Florida Proton Therapy Institute Prospective Registry Studies.
    Badiyan SN; Rutenberg MS; Hoppe BS; Mohindra P; Larson G; Hartsell WF; Tsai H; Zeng J; Rengan R; Glass E; Katz S; Vargas C; Feigenberg SJ; Simone CB
    Pract Radiat Oncol; 2019; 9(4):280-288. PubMed ID: 30802618
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The role of proton beam therapy in central neurocytoma: A single-institution experience.
    Kang KH; Schapira E; Niemierko A; Martinez-Lage M; Bussière MR; Yock TI; Loeffler JS; Butler WE; Carter BS; Shih HA
    Pract Radiat Oncol; 2018; 8(5):e305-e311. PubMed ID: 29706302
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Salvage Carbon Ion Radiation Therapy for Locally Recurrent or Radiation-Induced Second Primary Sarcoma of the Head and Neck.
    Yang J; Gao J; Wu X; Hu J; Hu W; Kong L; Lu JJ
    J Cancer; 2018; 9(12):2215-2223. PubMed ID: 29937942
    [No Abstract]   [Full Text] [Related]  

  • 24. Reduced-dose craniospinal irradiation for central nervous system relapsed neuroblastoma.
    Luo LY; Kramer K; Cheung NV; Kushner BH; Modak S; Basu EM; Roberts SS; Wolden SL
    Pediatr Blood Cancer; 2020 Sep; 67(9):e28364. PubMed ID: 32608559
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Extent of re-excision, sequence/timing of salvage re-irradiation, and disease-free interval impact upon clinical outcomes in recurrent/progressive ependymoma.
    Gupta T; Maitre M; Gupta P; Krishnatry R; Chatterjee A; Moiyadi A; Shetty P; Singh V; Chinnaswamy G; Epari S; Sahay A; Patil V; GodaSastri J
    J Neurooncol; 2020 Apr; 147(2):405-415. PubMed ID: 32072441
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Proton Beam Radiotherapy and Concurrent Chemotherapy for Unresectable Stage III Non-Small Cell Lung Cancer: Final Results of a Phase 2 Study.
    Chang JY; Verma V; Li M; Zhang W; Komaki R; Lu C; Allen PK; Liao Z; Welsh J; Lin SH; Gomez D; Jeter M; O'Reilly M; Zhu RX; Zhang X; Li H; Mohan R; Heymach JV; Vaporciyan AA; Hahn S; Cox JD
    JAMA Oncol; 2017 Aug; 3(8):e172032. PubMed ID: 28727865
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Proton beam therapy for muscle-invasive bladder cancer: A systematic review and analysis with Proton-Net, a multicenter prospective patient registry database.
    Araya M; Ishikawa H; Nishioka K; Maruo K; Asakura H; Iizumi T; Takagi M; Murakami M; Azuma H; Obara W; Aoyama H; Sakurai H
    J Radiat Res; 2023 Jun; 64(Supplement_1):i49-i58. PubMed ID: 37185773
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Outcomes of Patients With Primary Sacral Chordoma Treated With Definitive Proton Beam Therapy.
    Aibe N; Demizu Y; Sulaiman NS; Matsuo Y; Mima M; Nagano F; Terashima K; Tokumaru S; Hayakawa T; Suga M; Daimon T; Suzuki G; Hideya Y; Yamada K; Sasaki R; Fuwa N; Okimoto T
    Int J Radiat Oncol Biol Phys; 2018 Mar; 100(4):972-979. PubMed ID: 29485077
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Outcomes of multimodal therapy in a large series of patients with anaplastic thyroid cancer.
    Fan D; Ma J; Bell AC; Groen AH; Olsen KS; Lok BH; Leeman JE; Anderson E; Riaz N; McBride S; Ganly I; Shaha AR; Sherman EJ; Tsai CJ; Kang JJ; Lee NY
    Cancer; 2020 Jan; 126(2):444-452. PubMed ID: 31593317
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Proton beam therapy for olfactory neuroblastoma.
    Nakamura N; Zenda S; Tahara M; Okano S; Hayashi R; Hojo H; Hotta K; Kito S; Motegi A; Arahira S; Tachibana H; Akimoto T
    Radiother Oncol; 2017 Mar; 122(3):368-372. PubMed ID: 28062086
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Salvage prostate re-irradiation using high-dose-rate brachytherapy or focal stereotactic body radiotherapy for local recurrence after definitive radiation therapy.
    Mbeutcha A; Chauveinc L; Bondiau PY; Chand ME; Durand M; Chevallier D; Amiel J; Kee DL; Hannoun-Lévi JM
    Radiat Oncol; 2017 Mar; 12(1):49. PubMed ID: 28274241
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Systematic assessment of clinical outcomes and toxicities of proton radiotherapy for reirradiation.
    Verma V; Rwigema JM; Malyapa RS; Regine WF; Simone CB
    Radiother Oncol; 2017 Oct; 125(1):21-30. PubMed ID: 28941560
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Proton Therapy for Unresectable and Medically Inoperable Locally Advanced Pancreatic Cancer: Results From a Multi-Institutional Prospective Registry.
    Eckstein J; Choi JI; Lozano A; Ohri N; Press R; Hasan S; Kabarriti R; Chang J; Urbanic J; Durci M; Mohammed N; Stevens C; Tsai H; Apisarnthanarax S; Regine W; Vargas C; Nichols R; Herman J; Simone CB; Chhabra A
    Adv Radiat Oncol; 2023; 8(5):101250. PubMed ID: 37408677
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical results of proton beam therapy for advanced neuroblastoma.
    Oshiro Y; Mizumoto M; Okumura T; Sugahara S; Fukushima T; Ishikawa H; Nakao T; Hashimoto T; Tsuboi K; Ohkawa H; Kaneko M; Sakurai H
    Radiat Oncol; 2013 Jun; 8():142. PubMed ID: 23758770
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Compartmental intrathecal radioimmunotherapy: results for treatment for metastatic CNS neuroblastoma.
    Kramer K; Kushner BH; Modak S; Pandit-Taskar N; Smith-Jones P; Zanzonico P; Humm JL; Xu H; Wolden SL; Souweidane MM; Larson SM; Cheung NK
    J Neurooncol; 2010 May; 97(3):409-18. PubMed ID: 19890606
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical Outcome of Sacral Chordoma Patients Treated with Pencil Beam Scanning Proton Therapy.
    Walser M; Bojaxhiu B; Kawashiro S; Tran S; Beer J; Leiser D; Pica A; Bachtiary B; Weber DC
    Clin Oncol (R Coll Radiol); 2021 Dec; 33(12):e578-e585. PubMed ID: 34340918
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Proton beam radiotherapy vs. radiofrequency ablation for recurrent hepatocellular carcinoma: A randomized phase III trial.
    Kim TH; Koh YH; Kim BH; Kim MJ; Lee JH; Park B; Park JW
    J Hepatol; 2021 Mar; 74(3):603-612. PubMed ID: 33031846
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Proton-beam therapy for olfactory neuroblastoma.
    Nishimura H; Ogino T; Kawashima M; Nihei K; Arahira S; Onozawa M; Katsuta S; Nishio T
    Int J Radiat Oncol Biol Phys; 2007 Jul; 68(3):758-62. PubMed ID: 17398027
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pilot study of postoperative reirradiation, chemotherapy, and amifostine after surgical salvage for recurrent head-and-neck cancer.
    Machtay M; Rosenthal DI; Chalian AA; Lustig R; Hershock D; Miller L; Weinstein GS; Weber RS
    Int J Radiat Oncol Biol Phys; 2004 May; 59(1):72-7. PubMed ID: 15093901
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Stereotactic body re-irradiation therapy for locally recurrent prostate cancer after external-beam radiation therapy: Initial report.
    Janoray G; Reynaud-Bougnoux A; Ruffier-Loubière A; Bernadou G; Pointreau Y; Calais G
    Cancer Radiother; 2016 Jun; 20(4):275-81. PubMed ID: 27342944
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.